Cell cycle, CDKs and cancer: a changing paradigm

Cited by (1,005)

Items 501–600 of 1,005

1. Sodium propionate exerts anticancer effect in mice bearing breast cancer cell xenograft by regulating JAK2/STAT3/ROS/p38 MAPK signaling
   Hyun-Soo Park, Joo‐Hui Han, Jeong Won Park, Do-Hyung Lee, Keun‐Woo Jang, Miji Lee, Kyung‐Sun Heo, Chang‐Seon Myung · 2020 · Acta Pharmacologica Sinica
2. Recent Advances in PROTACs for Drug Targeted Protein Research
   Tingting Yao, Heng Xiao, Hong Wang, Xiaowei Xu · 2022 · International Journal of Molecular Sciences
3. The chondrocytic journey in endochondral bone growth and skeletal dysplasia
   Kwok Yeung Tsang, Shun Wa Tsang, Danny Tat-Ming Chan, Kathryn S.E. Cheah · 2014 · Birth Defects Research Part C Embryo Today Reviews
4. The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation
   Elena Shinderman‐Maman, Keren Cohen, C Weingarten, Dan Nabriski, Orit Twito, L Baraf, Aleck H. Hercbergs, Paul J. Davis, Haim Werner, Martin H. Ellis et al. · 2015 · Oncogene
5. Non-mitotic functions of the Anaphase-Promoting Complex
   Manuel Eguren, Eusebio Manchado, Marcos Malumbres · 2011 · Seminars in Cell and Developmental Biology
6. Long non-coding RNA SNHG15 inhibits P15 and KLF2 expression to promote pancreatic cancer proliferation through EZH2-mediated H3K27me3
   Zhonghua Ma, Hesuyuan Huang, Jirong Wang, Yan Zhou, Fuxing Pu, Qinghong Zhao, Peng Peng, Bingqing Hui, Hao Ji, Keming Wang · 2017 · Oncotarget
7. CDK4 is an essential insulin effector in adipocytes
   Sylviane Lagarrigue, Isabel C. López‐Mejía, Pierre‐Damien Denechaud, Xavier Escoté, Judit Castillo‐Armengol, Verónica Jiménez, Carine Chavey, Albert Giralt, Qiuwen Lai, Lianjun Zhang et al. · 2015 · Journal of Clinical Investigation · Retracted
8. Effect of PEG Grafting Density and Hydrodynamic Volume on Gold Nanoparticle–Cell Interactions: An Investigation on Cell Cycle, Apoptosis, and DNA Damage
   Metin Uz, Volga Bulmuş, Sacide Alsoy Altınkaya · 2016 · Langmuir
9. Clinical Trials and Progress in Metastatic Colon Cancer
   Kabir Mody, Tanios Bekaii‐Saab · 2018 · Surgical Oncology Clinics of North America
10. The multifaceted role of cell cycle regulators in the coordination of growth and metabolism
    Katharina Huber, Alberto Mestres‐Arenas, Lluís Fajas, Lucía C. Leal-Esteban · 2020 · FEBS Journal
11. A comprehensive review on phytochemistry, bioactivities, toxicity studies, and clinical studies on Ficus carica Linn. leaves
    Zhongyuan Li, Ying Yang, Miaomiao Liu, Chenghua Zhang, Junjing Shao, Xuewen Hou, Jingzhen Tian, Qinghua Cui · 2021 · Biomedicine & Pharmacotherapy
12. Kinase Inhibitors as Underexplored Antiviral Agents
    Javier Garcı́a-Cárceles, Elena Caballero, Carmen Gil, Ana Martı́nez · 2021 · Journal of Medicinal Chemistry
13. Genome homeostasis defects drive enlarged cells into senescence
    Sandhya Manohar, Marianna E. Estrada, Federico Uliana, Karla Vuina, Patricia Moyano Alvarez, Robertus A.M. de Bruin, Gabriel E. Neurohr · 2023 · Molecular Cell
14. Evodiamine induces apoptosis and inhibits metastasis in MDA-MB-231 human breast cancer cells in vitro and in vivo
    Jia Du, Xiufeng Wang, Qianmei Zhou, TIAN-LING ZHANG, Yi-Yu Lu, Hui Zhang, Shi-Bing Su · 2013 · Oncology Reports
15. Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
    Rakesh Dachineni, D. Ramesh Kumar, Eduardo Alberto Callegari, Siddharth Shivkumar Kesharwani, Ranjini Sankaranarayanan, Teresa M. Seefeldt, Hemachand Tummala, G. Jayarama Bhat · 2017 · International Journal of Oncology
16. Antiproliferative efficacy of curcumin mimics through microtubule destabilization
    Sadiya Khwaja, Kaneez Fatima, Mohammad Hasanain, Chittaranjan Behera, Avneet Kour, Arjun Singh, Suaib Luqman, Jayanta Sarkar, Debabrata Chanda, Karuna Shanker et al. · 2018 · European Journal of Medicinal Chemistry
17. Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation
    Tingjun Lei, Peixuan Zhang, Xudong Zhang, Xue Xiao, Jingli Zhang, Tong Qiu, Qian Dai, Yujun Zhang, Ling Min, Qian Li et al. · 2018 · Nature Communications
18. Roles of CDK/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression
    Pascal Loyer, Janeen H. Trembley · 2020 · Seminars in Cell and Developmental Biology
19. Cyclin E Deregulation Promotes Loss of Specific Genomic Regions
    Leonardo K. Teixeira, Xianlong Wang, Yongjiang Li, Susanna Ekholm‐Reed, Xiaohua Wu, Pei Wang, Steven I. Reed · 2015 · Current Biology
20. Effects of baicalein on apoptosis, cell cycle arrest, migration and invasion of osteosarcoma cells
    Yi Zhang, Lu Song, Lin Cai, Renxiong Wei, Hao Hu, Wei Jin · 2012 · Food and Chemical Toxicology
21. Induction of apoptosis, stimulation of cell-cycle arrest and inhibition of angiogenesis make human amnion-derived cells promising sources for cell therapy of cancer
    Hassan Niknejad, Ghasem Yazdanpanah, Abolhassan Ahmadiani · 2016 · Cell and Tissue Research
22. Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer
    Natalie A. Jabbour-Leung, Xian Chen, Tuyen N. Bui, Yufeng Jiang, Dong Yang, Smruthi Vijayaraghavan, Mark J. McArthur, Kelly K. Hunt, Khandan Keyomarsi · 2016 · Molecular Cancer Therapeutics
23. CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib
    Eric Raspé, Katia Coulonval, Jaime Miguel Gomes Pita, Sabine Paternot, Françoise Rothé, Laure Twyffels, Sylvain Brohée, Ligia Craciun, Denis Larsimont, Véronique Kruys et al. · 2017 · EMBO Molecular Medicine
24. Activation of the p53 Transcriptional Program Sensitizes Cancer Cells to Cdk7 Inhibitors
    Sampada Kalan, Ramon Amat, Miriam Merzel Schachter, Nicholas P. Kwiatkowski, Brian J. Abraham, Yanke Liang, Tinghu Zhang, Calla M. Olson, Stéphane Larochelle, Richard A. Young et al. · 2017 · Cell Reports
25. Oleandrin: A bioactive phytochemical and potential cancer killer via multiple cellular signaling pathways
    Nazia Kanwal, Azhar Rasul, Ghulam Hussain, Haseeb Anwar, Muhammad Ajmal Shah, Iqra Sarfraz, Ammara Riaz, Rabia Batool, Muhammad Shahbaz, Arif Hussain et al. · 2020 · Food and Chemical Toxicology
26. Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation – A systematic computational approach to discover novel cancer therapeutics
    Bharath Kumar Chagaleti, Shantha Kumar B., G. V. Anjana, Rajakrishnan Rajagopal, Ahmed Alfarhan, Jesu Arockiaraj, Kathiravan Muthu Kumaradoss, S. Karthick Raja Namasivayam · 2024 · Computational Biology and Chemistry
27. Dysregulation of CDK8 and Cyclin C in tumorigenesis
    Wu Xu, Jun‐Yuan Ji · 2011 · Journal of genetics and genomics/Journal of Genetics and Genomics
28. Salinomycin induces cell death via inactivation of Stat3 and downregulation of Skp2
    K H Koo, Hyeryeong Kim, Y-K Bae, Kyounghyun Kim, B-K Park, C-H Lee, Y-N Kim · 2013 · Cell Death and Disease
29. A retro-inverso cell-penetrating peptide for siRNA delivery
    Anaïs Vaissière, Gudrun Aldrian, Karidia Konate, Mattias F. Lindberg, Carole Jourdan, Anthony Telmar, Quentin Seisel, Frédéric Fernandez, Véronique Viguier, Coralie Genevois et al. · 2017 · Journal of Nanobiotechnology
30. Neutrophil Suppresses Tumor Cell Proliferation via Fas /Fas Ligand Pathway Mediated Cell Cycle Arrested
    Bingwei Sun, Weiting Qin, Mingming Song, Lu Liu, Yu Yao, Xinxin Qi, Hui Sun · 2018 · International Journal of Biological Sciences
31. Inhibition of stearoyl CoA desaturase‐1 activity suppresses tumour progression and improves prognosis in human bladder cancer
    Chiyuan Piao, Xiaolu Cui, Bo Zhan, Jun Li, Zeliang Li, Zhenhua Li, Xiankui Liu, Jianbin Bi, Zhe Zhang, Chuize Kong · 2018 · Journal of Cellular and Molecular Medicine
32. Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure
    Riham Abouleisa, Abou Bakr M. Salama, Qinghui Ou, Xian-Liang Tang, Mitesh Solanki, Yiru Guo, Yibing Nong, Lindsey McNally, Pawel Konrad Lorkiewicz, Kamal M. Kassem et al. · 2022 · Circulation
33. Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts
    Zhouling Xie, Shuzeng Hou, Xiaoxiao Yang, Yajun Duan, Jihong Han, Qin Wang, Chenzhong Liao · 2022 · Journal of Medicinal Chemistry
34. Anti-tumour effects of elatol, a marine derivative compound obtained from red algae Laurencia microcladia
    Andreza Campos, Christiane Borges Souza, Cíntia Lhullier, Miriam B. Falkenberg, Eloir Paulo Schenkel, Rosa Maria Ribeiro‐do‐Valle, Jarbas Mota Siqueira · 2012 · Journal of Pharmacy and Pharmacology
35. Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3- d ]pyrimidine-6-carbonitrile ( 7x ) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)
    M. V. Ramana Reddy, Balireddy Akula, Stephen C. Cosenza, Sai Krishna Athaluri Divakar, Muralidhar Reddy Mallireddigari, Venkat R. Pallela, Vinay K. Billa, D. R. C. Venkata Subbaiah, E. Vijaya Bharathi, Rodrigo Vasquez‐Del Carpio et al. · 2014 · Journal of Medicinal Chemistry
36. Differential Effects of Polyphenols on Proliferation and Apoptosis in Human Myeloid and Lymphoid Leukemia Cell Lines
    Amani A. Mahbub, Christine Lyn Le Maitre, Sarah Haywood‐Small, Gordon J. McDougall, Neil Alan Cross, Nicola Jordan · 2013 · Anti-Cancer Agents in Medicinal Chemistry
37. Cyclin-dependent kinase 11p110 (CDK11p110) is crucial for human breast cancer cell proliferation and growth
    Yubing Zhou, Chao Han, Duolu Li, Zujiang Yu, Fengmei Li, Feng Li, Qi An, Huili Bai, Xiaojian Zhang, Zhenfeng Duan et al. · 2015 · Scientific Reports
38. Systematic study of the dynamics and half-lives of newly synthesized proteins in human cells
    Weixuan Chen, Johanna M. Smeekens, Ronghu Wu · 2015 · Chemical Science
39. Cell cycle regulation of hematopoietic stem or progenitor cells
    Sha Hao, Chen Chen, Tao Cheng · 2016 · International Journal of Hematology
40. Highly Potent, Selective, and Orally Bioavailable 4-Thiazol- N -(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation
    Solomon Tadesse, Mingfeng Yu, Laychiluh Bantie Mekonnen, Frankie Lam, Saiful Islam, Khamis Tomusange, Muhammed Hamidur Rahaman, Benjamin D. Noll, Sunita K. C. Basnet, Theodosia Teo et al. · 2017 · Journal of Medicinal Chemistry
41. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma
    Yahong Wang, Ting Chen, Haili Huang, Yun Jiang, Lawei Yang, Ziying Lin, Huijuan He, Tie Liu, Bin Wu, Jie Chen et al. · 2017 · Oncotarget
42. miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3
    Yi Zhang, Wei Min Huang, Yan Ran, Yan Xiong, Zibiao Zhong, Xiaoli Fan, Zhenghua Wang, Qifa Ye · 2015 · Tumor Biology
43. Versatile Strategy for Biochemical, Electrochemical and Immunoarray Detection of Protein Phosphorylations
    Sanela Martić, Michelle A. Gabriel, Jacob P. Turowec, David W. Litchfield, Heinz‐Bernhard Kraatz · 2012 · Journal of the American Chemical Society
44. Blue intensity matters for cell cycle profiling in fluorescence DAPI-stained images
    Anabela Ferro, Tânia Mestre, Patrı́cia Carneiro, Ivan Andriiovych Sahumbaiev, Raquel Seruca, João Sanches · 2017 · Laboratory Investigation
45. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1
    S-H Chen, Xutong Gong, Youyan Zhang, Robert Daniel Van Horn, Tinggui Yin, L Huber, ThomasG. Burke, Jason R. Manro, Philip W. Iversen, Wenjuan Wu et al. · 2017 · Oncogene
46. Human hepatocellular carcinoma: Protection by melatonin
    Keywan Mortezaee · 2018 · Journal of Cellular Physiology
47. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer
    Siqi Bao, Ting Hu, Jiaqi Liu, Jianzhong Su, Jie Sun, Yue Ming, Jiaxin Li, Nan Wu, Hongyan Chen, Meng Zhou · 2021 · Journal of Nanobiotechnology
48. Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies
    Sajjad Vakili‐Samiani, Abduladheem Turki Jalil, Walid Kamal Abdelbasset, Alexei Valerievich Yumashev, Vahid Karpisheh, Pooya Jalali, Sara Adibfar, Majid Ahmadi, Abbas Ali Hosseinpour Feizi, Farhad Jadidi‐Niaragh · 2021 · DNA repair
49. cGAS/STING cross-talks with cell cycle and potentiates cancer immunotherapy
    Zi‐Jie Long, Jundan Wang, Jue‐Qiong Xu, Xinxing Lei, Quentin Liu · 2022 · Molecular Therapy
50. Price To Be Paid for Two-Metal Catalysis: Magnesium Ions That Accelerate Chemistry Unavoidably Limit Product Release from a Protein Kinase
    Douglas M. Jacobsen, Zhao Bao, Patrick O’Brien, Charles L. Brooks, Matthew Adam Young · 2012 · Journal of the American Chemical Society
51. 5‐ D emethyltangeretin inhibits human nonsmall cell lung cancer cell growth by inducing G 2/M cell cycle arrest and apoptosis
    Noppawat Charoensinphon, Peiju Qiu, Ping Dong, Jinkai Zheng, Pearline Ngauv, Yong Cao, Shiming Li, Chi‐Tang Ho, Hang Xiao · 2013 · Molecular Nutrition & Food Research
52. Mitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2
    Ignacío Pérez de Castro, Marcos Malumbres · 2012 · Genes & Cancer
53. Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician
    Stéphanie Lheureux, Christophe Denoyelle, Pamela S. Ohashi, Johann Sebastian De Bono, Felix Manuel Mottaghy · 2017 · European Journal of Nuclear Medicine and Molecular Imaging
54. Differences in MWCNT- and SWCNT-induced DNA methylation alterations in association with the nuclear deposition
    Deniz Öner, Manosij Ghosh, Hannelore Bové, Matthieu Moisse, Bram Boeckx, Radu Corneliu Duca, Katrien L. C. Poels, Katrien Luyts, Eveline Putzeys, Kirsten L. VAN LANDUYT et al. · 2018 · Particle and Fibre Toxicology
55. HDAC3 controls gap 2/mitosis progression in adult neural stem/progenitor cells by regulating CDK1 levels
    Jiang, Yindi, Hsieh, Jenny · 2014 · Proceedings of the National Academy of Sciences
56. MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation
    Harikrishnan Radhakrishnan, Wolfgang Walther, Fabian Zincke, Dennis Kobelt, Francesca Imbastari, Müge Erdem, Benedikt Kortüm, Mathias Dahlmann, Ulrike Stein · 2018 · Cancer and Metastasis Reviews
57. Quantitation of Molecular Pathway Activation Using RNA Sequencing Data
    Nicolas M. Borisov, Maxim Sorokin, Andrew Garazha, Anton A. Buzdin · 2019 · Methods in molecular biology
58. Icariside II inhibits tumorigenesis via inhibiting AKT/Cyclin E/ CDK 2 pathway and activating mitochondria-dependent pathway
    Yasai Sun, Kiran Thakur, Fei Hu, Jian‐Guo Zhang, Zhao‐Jun Wei · 2019 · Pharmacological Research
59. Cell Cycle Activation and Spinal Cord Injury
    Junfang Wu, Bogdan A. Stoica, Alan I. Faden · 2011 · Neurotherapeutics
60. Overexpression of CDCA2 in Human Squamous Cell Carcinoma: Correlation with Prevention of G1 Phase Arrest and Apoptosis
    Fumihiko Uchida, Katsuhiro Uzawa, Atsushi Kasamatsu, Hiroaki Takatori, Yosuke Sakamoto, Katsunori Ogawara, Masashi Shiiba, Hiroki Bukawa, Hideki Tanzawa · 2013 · PLoS ONE
61. Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma
    Karolin H. Nord, Linda Magnusson, Margareth Isaksson, Jenny Nilsson, Henrik Lilljebjörn, Henryk A. Domanski, Lars‐Gunnar Kindblom, Nils Mandahl, Fredrik Mertens · 2010 · Proceedings of the National Academy of Sciences
62. Redeployment of Myc and E2f1–3 drives Rb-deficient cell cycles
    Huayang Liu, Xing Tang, Arunima Srivastava, Thierry Pécot, Piotr Daniel, Benjamin T. Hemmelgarn, Stephan Reyes, Nicholas Fackler, Amneet Bajwa, Raleigh D. Kladney et al. · 2015 · Nature Cell Biology
63. LINE-1 Hypomethylation, DNA Copy Number Alterations, and CDK6 Amplification in Esophageal Squamous Cell Carcinoma
    Yoshifumi Baba, Masayuki Watanabe, Asuka Murata, Hironobu Shigaki, Keisuke Miyake, Takatsugu Ishimoto, Masaaki Iwatsuki, Shiro Iwagami, Naoya Yoshida, Eiji Oki et al. · 2014 · Clinical Cancer Research
64. The Convergent Cancer Evolution toward a Single Cellular Destination
    Han Chen, Xionglei He · 2015 · Molecular Biology and Evolution
65. CDK4 Phosphorylates AMPKα2 to Inhibit Its Activity and Repress Fatty Acid Oxidation
    Lopez-Mejia, Isabel C., Lagarrigue, Sylviane, Giralt, Albert, Martinez-Carreres, Laia, Zanou, Nadège, Denechaud, Pierre-Damien, Castillo-Armengol, Judit, Chavey, Carine, Orpinell, Meritxell, Delacuisine, Brigitte et al. · 2017 · Molecular Cell
66. Oncogenic KRAS signaling and YAP1/β-catenin: Similar cell cycle control in tumor initiation
    Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang, Tamás Korcsmáros, Péter Csermely · 2016 · Seminars in Cell and Developmental Biology
67. Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors
    Srinivasulu Cherukupalli, Balakumar Chandrasekaran, Vladimı́r Kryštof, Rajeshwar Reddy Aleti, Nisar Sayyad, Srinivas Reddy Merugu, Narva Deshwar Kushwaha, Rajshekhar V. Karpoormath · 2018 · Bioorganic Chemistry
68. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells
    Ah‐Won Kwak, Myeoung-Jun Lee, Mee-Hyun Lee, Goo Yoon, Seung‐Sik Cho, Jung‐Il Chae, Jung‐Hyun Shim · 2021 · Phytomedicine
69. Key Proteins of Replication Stress Response and Cell Cycle Control as Cancer Therapy Targets
    Alvina I. Khamidullina, Yaroslav E. Abramenko, Alexandra V. Bruter, Victor Vyacheslavovich Tatarskiy · 2024 · International Journal of Molecular Sciences
70. Transcriptome sequencing of neonatal thymic epithelial cells
    Charles St-Pierre, Sylvie Brochu, Juan Ruiz Vanegas, Maude Dumont-Lagacé, Sébastien Lemieux, Claude Perreault · 2013 · Scientific Reports
71. A Comprehensive Review of Dysregulated miRNAs Involved in Cervical Cancer
    Garima Sharma, Pradeep Kumar Dua, Subhash Mohan Agarwal · 2014 · Current Genomics
72. Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-β expression
    Kyung‐Sook Chung, Sung‐Hee Cho, Ji‐Sun Shin, Dong-Hyun Kim, Jung‐Hye Choi, Sang Yoon Choi, Young Kyoung Rhee, Hee‐Do Hong, Kyung‐Tae Lee · 2012 · Carcinogenesis
73. High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
    M. P. H. M. Jansen, Esther Anneke Reijm, Anieta M. Sieuwerts, Kirsten Ruigrok-Ritstier, Maxime P. Look, Francisco Germán Rodríguez-González, Anouk A. J. Heine, John W.M. Martens, Stefan Sleijfer, John A. Foekens et al. · 2011 · Breast Cancer Research and Treatment
74. Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer
    Shinta Tan, Elisabeth G.E. de Vries, Ate G.J. van der Zee, Steven de Jong · 2012 · Current Cancer Drug Targets
75. KCTD12 promotes tumorigenesis by facilitating CDC25B/CDK1/Aurora A-dependent G2/M transition
    Y Zhong, Jie Yang, W W Xu, Yang Wang, C-C Zheng, Bin Li, Qing‐Yu He · 2017 · Oncogene
76. Isoliquiritigenin Induces Autophagy and Inhibits Ovarian Cancer Cell Growth
    Hsin-Yuan Chen, Tsui‐Chin Huang, Tzong‐Ming Shieh, Chih‐Hsiung Wu, Li-Chun Lin, Shih‐Min Hsia · 2017 · International Journal of Molecular Sciences
77. Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells
    Xi Chen, Xiushuai Dong, Haiyan Gao, Yongfang Jiang, Yinglan Jin, Yu‐Ying Chang, Liyan Chen, Jing‐Hua Wang · 2015 · Molecular Medicine Reports
78. Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells
    Wenfeng Lin, Jinlin Xie, Naijin Xu, Linglong Huang, Xun Xu, Hulin Li, Chaoming Li, Yubo Gao, Masami Watanabe, Chunxiao Liu et al. · 2018 · International Journal of Biological Sciences
79. ANP 32E induces tumorigenesis of triple‐negative breast cancer cells by upregulating E2F1
    Zhenchong Xiong, Liping Ye, Zhen‐Yu He, Feng‐Yan Li, Yahui Xiong, Chuyong Lin, Xianqiu Wu, Guangzheng Deng, Wei Shi, Libing Song et al. · 2018 · Molecular Oncology
80. Iron and liver cancer: an inseparable connection
    Keisuke Hino, Izumi Yanatori, Yuichi Hara, Sohji Nishina · 2021 · FEBS Journal
81. Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives
    Maniyamma Aswathy, Ajesh Vijayan, Uzini Devi Daimary, Sosmitha Girisa, Kokkuvayil Vasu Radhakrishnan, Ajaikumar Bahulayan Kunnumakkara · 2022 · Journal of Biochemical and Molecular Toxicology
82. Ruthenium–Arene–β‐Carboline Complexes as Potent Inhibitors of Cyclin‐Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies
    Liang He, Siyan Liao, Cai‐Ping Tan, Rui‐Rong Ye, Yu‐Wen Xu, Meng Liang Zhao, Liang‐Nian Ji, Zong‐Wan Mao · 2013 · Chemistry - A European Journal
83. MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer
    Balabhadrapatruni V. S. K. Chakravarthi, Moloy T. Goswami, Satya S. Pathi, Alyncia D. Robinson, Marcin P. Cieslik, Darshan Shimoga Chandrashekar, Sumit Agarwal, Javed Siddiqui, Stephanie D. Daignault, Shannon L. Carskadon et al. · 2016 · Oncogene
84. Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value
    Yangmei Zhou, Yang Li, Xiaoxi Zhang, Rui Chen, Xiuqiong Chen, Wenhua Tang, Mengxian Zhang · 2019 · BioMed Research International
85. CDK8 maintains stemness and tumorigenicity of glioma stem cells by regulating the c-MYC pathway
    Kazuya Fukasawa, Takuya Kadota, Tetsuhiro Horie, Kazuya Tokumura, Ryuichi Terada, Yuka Kitaguchi, Gyujin Park, Shinsuke Ochiai, Sayuki Iwahashi, Yasuka Okayama et al. · 2021 · Oncogene
86. Dominant role of CDKN2B/p15INK4B of 9p21.3 tumor suppressor hub in inhibition of cell-cycle and glycolysis
    Yong Xia, Yan Liu, Chao Yang, Diane M. Simeone, Tung‐Tien Sun, David J. DeGraff, Moon-shong Tang, Yingkai Zhang, Xue‐Ru Wu · 2021 · Nature Communications
87. The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
    Getinet Mequanint Adinew, Equar Taka, Patricia Mendonca, Samia S. Messeha, Karam F. A. Soliman · 2021 · Nutrients
88. Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma
    Christopher Abdullah, Xiaolei Wang, Dorothea Becker · 2011 · Cell Cycle
89. Fluorescent biosensors — Probing protein kinase function in cancer and drug discovery
    May Catherine Morris · 2013 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
90. Cyclin-dependent kinase inhibitors: a survey of recent patent literature
    Hervé Galons, Nassima Oumata, Laurent Meijer · 2010 · Expert Opinion on Therapeutic Patents
91. Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma
    Jeng‐Wei Lu, Yueh‐Min Lin, Jan‐Gowth Chang, Kun‐Tu Yeh, Rong-Ming Chen, Jeffrey Tsai, Wei‐Wen Su, Rouh‐Mei Hu · 2013 · Medical Oncology
92. Recent Development of Hydrogen Sulfide Releasing/Stimulating Reagents and Their Potential Applications in Cancer and Glycometabolic Disorders
    Chuntao Yang, Li Chen, Shi Juan Xu, Jacob J. Day, Xiang Li, Ming Xian · 2017 · Frontiers in Pharmacology
93. Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
    Alireza Azimi, Stefano Caramuta, Brinton A. Seashore-Ludlow, Johan Boström, Jonathan L. Robinson, Fredrik Edfors, Rainer Tuominen, Kristel Kemper, Oscar Krijgsman, Daniel S. Peeper et al. · 2018 · Molecular Systems Biology
94. Juvenile hormone promotes locust fat body cell polyploidization and vitellogenesis by activating the transcription of Cdk6 and E2f1
    Zhongxia Wu, Wei Guo, Libin Yang, Qiongjie He, Shutang Zhou · 2018 · Insect Biochemistry and Molecular Biology
95. MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis
    Jian-Guo Wu, Jin-Jie Wang, Xin Jiang, Jianping Lan, Xujun He, Hui‐Ju Wang, Yingyu Ma, Yingjie Xia, Guoqing Ru, Jie Ma et al. · 2014 · Gastric Cancer
96. CDK4 T172 Phosphorylation Is Central in a CDK7-Dependent Bidirectional CDK4/CDK2 Interplay Mediated by p21 Phosphorylation at the Restriction Point
    Xavier Bisteau, Sabine Paternot, Colleoni Bianca, Karin Ecker, Katia Coulonval, Philippe De Groote, Wim Declercq, Ludger Hengst, Pierre P. Roger · 2013 · PLoS Genetics
97. Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs
    Toshikatsu Okumura · 2010 · Journal of Gastroenterology
98. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells
    Susan L. Whiteway, Peter S. Harris, Sujatha Venkataraman, Irina N. Alimova, Diane K. Birks, Andrew M. Donson, Nicholas K. Foreman, Rajeev Vibhakar · 2012 · Journal of Neuro-Oncology
99. Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination
    Chenggang Jiang, Ling Lv, Furong Liu, Zhen-Ning Wang, Funan Liu, Yanshu Li, Chun-Yu Wang, Hongyan Zhang, Zhe Sun, Huimian Xu · 2011 · Molecular Cancer
100. Palbociclib-induced autophagy and senescence in gastric cancer cells
     Claudio A. Valenzuela, Leandro Vargas, Valentina Martinez, Sindy Bravo, Nelson E. Brown · 2017 · Experimental Cell Research